Clinical Trials Browser

Phase 3 × INDUSTRY × Histamine Antagonists × Clear all

NCT06305754 2026-03-13

MK-2870-009

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06824467 2026-03-13

TroFuse-022

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00719472 2017-05-15

RATE

Phase 3 Completed

451 enrolled 11 charts

Lymphoma, Non-Hodgkin